Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning

被引:13
作者
Classen, CF
Schulz, AS
Sigl-Kraetzig, M
Hoffmann, GF
Simmonds, HA
Fairbanks, L
Debatin, KM
Friedrich, W
机构
[1] Univ Childrens Hosp Ulm, D-89073 Ulm, Germany
[2] Univ Childrens Hosp Heidelberg, Heidelberg, Germany
[3] Guys Hosp, Purine Res Unit, London SE1 9RT, England
关键词
purine nucleoside phosphorylase deficiency; SCID; bone marrow transplantation; fludarabine;
D O I
10.1038/sj.bmt.1703100
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
PNP deficiency is an autosomal recessive metabolic disorder characterized by severe combined immunodeficiency and by complex neurological symptomatology including ataxia, developmental delay and spasticity. Patients usually die in the first or second decade of life due to recurrent infections. The only curative treatment is bone marrow transplantation (BMT). We describe a 22-month-old girl who underwent BMT from her HLA-identical brother. Conditioning consisted of busulfan and fludarabine only, resulting in low toxicity and prompt engraftment. At 18 months after BMT, the girl has developed normal immunological functions, and her neurological status has improved.
引用
收藏
页码:93 / 96
页数:4
相关论文
共 20 条
[1]  
ANDREWS LG, 1992, J BIOL CHEM, V267, P7834
[2]  
AUST MR, 1992, AM J HUM GENET, V51, P763
[3]  
Carpenter PA, 1996, BONE MARROW TRANSPL, V17, P121
[4]   Nucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombination [J].
Gangi-Peterson, L ;
Sorscher, DH ;
Reynolds, JW ;
Kepler, TB ;
Mitchell, BS .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) :833-841
[5]   ADA AND PNP DEFICIENCIES - HOW IT ALL BEGAN [J].
GIBLETT, ER .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 451 (OCT) :1-8
[6]  
Hallett RJ., 1999, CELL MOL BIOL LETT, V4, P374
[7]   The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite:: time interval influence on therapeutic efficacy and therapy-related toxicity [J].
Hassan, M ;
Ljungman, P ;
Ringdén, O ;
Hassan, Z ;
Öberg, G ;
Nilsson, C ;
Békassy, A ;
Bielenstein, M ;
Abdel-Rehim, M ;
Georén, S ;
Astner, L .
BONE MARROW TRANSPLANTATION, 2000, 25 (09) :915-924
[8]   INHERITED ENZYME DEFICIENCIES AND IMMUNODEFICIENCY - ADENOSINE-DEAMINASE (ADA) AND PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) DEFICIENCIES [J].
HIRSCHHORN, R .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 40 (01) :157-165
[9]   A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia [J].
Kapelushnik, J ;
Or, R ;
Slavin, S ;
Nagler, A .
BONE MARROW TRANSPLANTATION, 1997, 20 (12) :1109-1110
[10]  
MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45